References
- Cannon RD, Holmes AR, Mason AB, Monk BC. Oral Candida: clearance, colonization, or candidiasis? J Dent Res 1995; 74: 1152–1161.
- Edgerton M, Koshlukova SE. Salivary histatin 5 and its similarities to the other antimicrobial proteins in human saliva. Adv Dent Res 2000; 14: 16–21.
- Lamkin MS, Oppenheim FG. Structural features of salivary function. Crit Rev Oral Biol Med 1993; 4: 251–259.
- Lenander-Lumikari M. Inhibition of Candida albicans by the Peroxidase/SCN-/H2O2 system. Oral Microbiol 1992; 7: 315–320.
- Samaranayake YH, Samaranayake LP, Pow EH, Beena VT, Yeung KW. Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort. J Clin Microbiol 2001; 39: 3296–3302.
- Yang YL. Virulence factors of Candida species. J Microbiol Immunol Infect 2003; 36: 223–228.
- Sas R, Dawes C. The intra-oral distribution of unstimulated and chewing-gum-stimulated parotid saliva. Arch Oral Biol 1997; 42: 469–474.
- Shannon IL. Parotid fluid flow rate as related to whole saliva volume. Arch Oral Biol 1962; 7: 391–394.
- Pfaller MA, Messer SA, Boyken L, . Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp. J Clin Microbiol 2004; 42: 3137–3141.
- Powderly WG. Cryptococcosis. J Int Assoc Physicians AIDS Care 1996; 2: 28–31.
- Jensen JL, Lamkin MS, Oppenheim FG. Adsorption of human salivary proteins to hydroxyapatite: a comparison between whole saliva and glandular salivary secretions. J Dent Res 1992; 71: 1569–1576.
- Helmerhorst EJ, Venuleo C, Beri A, Oppenheim FG. Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins. Yeast 2005; 22: 705–714.